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COMMUNICATION  BY  THE  COMMISSION  TO  THE  COUNCIL 
PREAMBLE 
In  presenting  the  Guidelines  for  the  new  Community  Framework  Programme 
of  Research  and  Technological  Development  for  1987-1991  (COM  (86)  129 
final  of  17  March  1986),  the  Commission  has  stressed  the  importance 
which it attaches to  the  themes  of  : 
industrial  competitiveness  and,  through  it,  improvement  in  the 
employment  situation; 
the quality of  life; 
the realisation of  a  Researchers'  Europe. 
Numerous  initiatives  have  already  been  taken  by  means  of  Community 
research  and  technological development  programmes .'in  order  to  strengthen 
industrial  competitiveness.  It  seems  essential  to  pursue  these  efforts 
without  delay;  this  has  resulted  in  the  preparation  of  three  of  the 
following  four  communications  enclosed,  which  indicate  the  initiatives 
that  the  Commission  intends  to  take.with regard  to  : 
the  launching of  the  second  phase  of  the  ESPRIT  programme 
the revision of  the  BRITE  programme 
the  revision of  the BiOt;chnology programme. 
The  last  one  is  equally  relevant  to  efforts  to  improve  the  quality  of 
life of citizens of  the  Community. 
The  fourth  communication  enclosed  gives  more  details  of  how  the 
Commission  views  the  revision  of  the  Stimulation programme  on  exchanges 
of  researchers;  in  this  case  it demonstrates  the  intention  to  support 
wholeheartedly  the  efforts  being  made  to  achieve  a  true  Researchers' 
Europe. 
The  presentation  of  these  four  communications  aims  at  assuring  to 
provide  the  necessary  impetus  for  the  actions  already  undertaken  on 
these  priority  themes;  these  four  future  programmes  provide  a  good 
example  of  the priorities set by  the Commission. 
It  is further  self-evident  that,  in  the  spirit  of  the  "Single  European 
Act",  these  four  communications  prejudge  neither  the  result  of  the 
debate  going  on  in  the  Council and  the Parliament  on  the orientations of 
the  Framework  Programme  nor  the  formal  corresponding proposal which  the 
Commission will present  in  July  1986. 
Furthermore,  these  four  documents  do  not  prejudge  the  corresponding 
draft  decisions  which  will be  presented  later  on  to  the  Council  and  to 
the Parliament. REVIEW  OF  TilE  MULTIANNUAL  RESEARCH  PROGRAMME 
OF  THE  EUROPEAN  ECONOMIC  COMMUNITY 
IN  THE  FIELD  OF  BIOTECHNOLOGY  (1985  - 1989) 
COMMUNICATION  TO  COUNCIL 
1.  TERMS  OF  REFERENCE 
On  12  March  1985  the  Council  adopted  a:  multiannual  research  action 
programme  (1985  to  1989)  for  the  European  Economic  Community  in the  field 
of  biotechnology.  In  its  decision,  the  Council  made  provision  for  the 
programme ·to  be  reviewed  and  possibly revised during its second year. 
2.  VALUE  OF  COMMUNITY  TRAINING,  RESEARCH  AND  CONCERTATION  ACTIVITIES  IN 
MODERN  BIOTECHNOLOGY 
In recent years  the Council has  adopted  two  Community  R&D  programmes  in  the 
field  of  new  biotechnology  : 
a)  The  BEP,  Biomolecular  Engineering  Programme  (April  1982  - March  1986; 
budget  of  15 million  ECU),  which  led  to  the establishment of  an initial 
nucleus  of  Community  research  and  training  activities  for  the 
applications  of  enzyme  engineering  and  genetic  engineering  in 
agriculture and  the  food  industry; 
b)  The·  BAP,  Biotechnology  Research  Action  Programme  (1985-1989;  budget  of 
55  million  ECU)  to  continue  and  supplement  the  activities  carried  out 
under the  BEP. 
These  two  programmes  have  clearly  demonstrated  the  value  of  Community 
training,  research  and  concertation activities in biotechnology.  the  former 
by  its  excellent  results  and  the  latter  by  the  success  achieved  in  its 
initial stages.  Both  show the benefits  in the way  of project  implementation 
and  design obtained  through  the  Community  effort.  Both  bear witness  to  the 
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I interest  and  enthusiasm  shown  by:· national  laboratories  in  cross.:.frontier 
activities ·  that  allow  them  to · :combine  their  expertise  and  pool  the 
facilities,  materials  and  methods  essential  for  the  development  of 
biotechnology. 
2.1.  !!!~-~~~~E!~-~!:-~~~-~!~~~!~~~!~!:-~~S!~~~!:!!!S_E~£g~~~~-i~E!:!!_!2~~-~£ 
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Because  of  the  meagre  funds  available,  this  programme  was  focussed  on  the 
objectives  considered  to  be  the  most  urgent  and  important.  It  therefore 
covered  only  those  applications  of  biomolecular  engineering  which  were 
likely,  through  the  genetic  modification  of  agricultural  species  and  the 
improvement  of  processing  methods,  to  contribute  in  the  long  term  to  the 
resolution  of  certain  Community  agricultural  problems.  This  first  brief 
Community  experiment  in  the  very  complex  area  of  molecular  genetics  and 
enzymology  can  claim  to its credit 
success  in attracting a  large number of proposals, 
the  establishment  of  a  transnational network  of  research activities 
based  on  European cooperation, 
the  quality of  its scientific results  and  a  number  of  breakthroughs 
towards applications of significance for  the  Community. 
There  can  be  no  doubt  that  the  programme  was  successful  in  attracting 
proposals  since  almost  300  proposals,  in  the  main  from  the  best 
laboratories  in  the  Community,  were  received  in  response  to  the  call 
published  by  the, Commission.  From  this large number  the  Commission was  able 
to  select  only  those  projects  which  met  both  the  scientific  quality 
criteria  and  the  specific  objectives  of  the  programme.  The  selection  was 
possibly  too  rigorous  (slightly  less  than  one-third  of  the  proposals 
received  were  accepted)  since  lack  of  funds  prevented  many  very  valuable 
proposals  from  being  included  in  the  Community  programme.  Because  of  t;he 
lack of  funds  some  research  areas  (physiology  and  stability of  immobilized 
systems,  early detection of  genetic or pathological modifications,  etc)  had 
to  be  left out altogether. 
A  similar  success  was  achieved  in  the  case  of  training  activities  to 
complement  the  contract  research  programme.  More  than  200  young·scientist~ 
applied  to  take  part  in  these  activiti.es  and  84.  training  contracts  (for 
periods  of  from  6  ·to  24  months)  were  negotiated.  With  the  best  research 
centres  in  the  Community  serving  as  host  laboratories,  these  made  it 
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·The  63 ·cooperation. agreements . between ·the· 103 ·laboratories  .. taking -part . ·:!-!1.-: 
the  programme· bear  witness  to  the . resolutely  transnational  nature- .of  the 
BEP.  These  agreements  cover  both  · exchanges  of  research  scientists  and 
equipment  and .the  pooling of  certain infrastructure facilities  or  complete 
integration of activities. 
They  were  brought  about  or  encouraged  ·by  Commission  staff.  when  the 
programme  was  launched,  during  laboratory  visits.  and  at  the  16 
intrasectoral  or  multidisciplinary  meetings  organized  while  the  contract 
work  was·  in  progress·.  A  network  of  good  laboratories,  which  is still not 
large  enough  but  is extremely  receptive  to  cooperation  and  the  pooling  of 
effort,  has  thus  been  set  up  for  the  first  time  in  Europe  in  areas 
essential to  the  application of  modern  biology  in agriculture and  the  food 
industry  :  .development of bioreactors,  identification,  transfer and  cloning 
of  genes  of  significance  for  the  processing .of  agricultural  produce, 
improvement  of.· cultivated  species  and  soil· micro-organisms -through  genetic 
engineering,  application of biomolecular engineering. to  .stock  breeding  and 
veterinary medicine. 
The  final  point  is  the  volume  and  quality  of  the  scientific  achievements 
obtained under  the  BEP.  A few  examples  out of many  are given below  : 
..,.  The  transfer  by· contractors  in  three  different . countries  of  genetic 
*  information· into  a  few  species  belonging  to  a  group  of  plants  that is 
not  amenable  to  modern  genetic  engineering  methods.  ·This  is  .a  real 
world  first  as  no  other  group  had  until .then  obtained  such  a  decisive 
breakthrough  in  this  area.  This  result,  which  opens  the  door  to  major 
long-term  developments  in  the  field  of  plant  improvement,  would 
probably have  been obtained without  the  BEP  but obviously the  Community 
activity speeded it up. 
Sixteen  laboratories have  isolated and  characterized at molecular level 
more  than  20  different genes  governing  important properties in 
*Monocotyledons,  which  includefodder grasses and cereals 
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crop  plants  such  as  the  nutritional  properties  of  the  grain  of 
cereals or  legumes,  resistance  to  insect pests  and  the production of 
secondary  metabolites.  This  highly  complex  work  is  an  absolutely 
essential  preliminary  to  any  further  progress  through  genetic 
engineering.  at  the  end  of  1984,  in the  whole  world,  only  86  plant 
genes  (compared  to  1100  genes in mammals)  had  been partly described. 
The  merit  of  the  Community  programme  is  to  have  organized  the 
combining  of  effort  and  concentration  of  financing  suited  to  the 
scale of the problems  to  be  solved. 
The  construction of plasmids  and  cloning of numerous  genes  likely to 
perform  key  functions  in  dairy  fermentation,  the  production  of  new 
vaccines  and  the  transformation of  the constituents of  wood. 
The  development  of  bioreactors  involving  the  co-immobilization  of 
micro-organisms  and  enzymes  and  the  use  of  multienzymatic  systems 
necessary for  the regeneration of  expensive co-factors essential for 
the  synthesis  of  chemicals  of  industrial  interest  (steroids  for 
pharmaceutical  uses,  long-chain  aldehydes  as  food  additives, 
gluconic acid the pharmaceutical and  food  industries, etc.).  Some  of 
these  developme.nts are  now  in the pilot plant phase. 
These  successes  should  not,  however,  be  allowed  to  conceal  the  weaknesses 
of  the  BEP  which  certainly  suffered  greatly  from  the  inadequacy  of  its 
budget.  Community  support  for  work  under  contract  barely  exceeded  an 
average  of  50  000  ECU  per year  per laboratory,  i.e.  less  than the cost  of  a 
research  scientist  per  year  and  his  operating  expenses  in  most  Community 
countries.  University  researchers.  accustomed  to  the  austerity of  national 
budgets,  content  themselves  with  this  low  level of  financing  which  in  many 
cases  nevertheless  allows  them  to  increase  their  work  significantly.  The 
situation  is  different  in  industrial  laboratories  where  the  BEP  budget · 
often appeared modest  (see  2.2.1  below) • 
2.2.1  Research  and  training 
The  atm  of  this  programme,  launched  by  two  calls  for  proposals  in 
l9H:)  and  l ':J86;  is  to  continue,  expand  anJ  supplement  the  Community 
activities .under  the  BEP.  Its budget_ (55 million ECU)  is larger and. 
without  losing. sight of  the need  to  concentrate efforts,  the idea  i·s 
BR!./06 - •.  5  -to  expand  the  very  narrow  area  covered  by  the  BEP.  In  addition  to 
the  fields  covered  by  the  BEP,  the  programme  makes  provision  for 
contextual  measures  for  the  pooling  and  improvement  of  existing  R&D 
support  facilities  in  the  Member  States  (information  storage  and 
processing,  collections  of  biotic  materials)  and  specific  projects 
for  protein  design,  the  applications  of  genetic  engineering  to 
industrial  micro....,organism.s  and  the  development  of  new  in  vitro 
systems  for  assessment  of  the  pharmacological  and  toxicological 
properties  of molecules.  All  these  new activities have  been  defined 
in  the  light  of  Community  requirements  (need  to  focus  research  on 
objectives  suited  to  industrial  requirements,  long-term 
contribution,  by·;' the  application  of  research  results  to  the 
evolution of  Comm~nity agriculture,  establishment of scientific data 
needed  to prepare;Community standards and  regulations,  assessment  of 
potential  risks) .~{The  aim,  for  each  of  the  topics  selected,  is  to 
). 
enable  the  Community  to  benefit  from  the  very  high  value  added 
obtained  by  the  pooling  of  research  facilities  and  the  combining  of 
the  research effort across frontiers. 
As  far  as  implemehtation  is  concerned,  the  main  procedures  defined 
for  the  BEP  wilL-.be  used  for  the  training  and  research  activities 
under  the BAP.  In;::order  to  increase international cooperation as  far 
as  possible,  a  very  high  priority  was  given  in  the  selection  of 
research  projects·o·to  combined  proposals  from  laboratories  situated 
in different Member  States. 
A  high  priority,:.  is  also  given  to  proposals  from  industrial 
laboratories  or· f(itVolving  the  direct  or  indirect  participation  of 
' ... 
industry.  The  r~search  contracts  contain. specific  clauses  for  the 
protection of  ~nt~llectual property. 
After  publication  of  the  calls  for  proposals,  the  Commission 
received  proposals  for  more  than  1300  projects  by  1  March  1986.The 
proportion  of  proposals  selected  will  probably  be  less  than 
one-seventh  of  those  received  and  it is already clear  from the.first 
selection  meetings  that  many  many  high-quality  proposals  will  have 
to  be  rejected.  This  proposal  for  the  review  of  the  programme  is 
designed  to  avoid  that  eventuality,  which  would  have  a  deplorable 
effect  on  the enthusiasm  and  obvious  desire of  European  Laboratories 
to  associate  themselves  in  transnational networks  and  work  together 
in the  Community  context.  It would  also mean neglecting,  for  lack of 
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adequate  funds,  numerous  areas  of  the  programme  in which only  a  few 
laboratories could  enjoy  Community  support. 
The  review of  the  programme  as  proposed  here  would  also  put  to  good 
use  the  marked  swing  in  European  industry  in  favour  of  Community 
activites  in  biotechnology.  This  started  in  the  last  two  years_  of 
the  BEP  when  a  relatively  high  number  of  industrial  laboratories 
asked  to  be  included  in  the  networks  of  contractors  set  up  for  each 
part of  the ,programme.  It gathered  momenttnn  under  the  existing  BAP, 
in  partic~lar through  the declarations  of ,interest by industry which 
accompanied  most  of  the.  research  proposals -submitted  by university 
or  national  laboratories.  The  time  is  ri~'e 'for  the  finalization  of 
cooperation ·and/or  joint  financing  agreements  (see  4.2)  between 
these  laboratories  and·  the  industrial. ffrriis  which  have  expressed 
interest in  the research plans. 
2.2.2.  Concertation 
Biotechnology  research,  whether  included  irt~.  Community,  national  or 
--
industrial  programmes  in  Europe  and  elsewhe-re  in  the  world,  is  the 
first stage  in  a  process  that must  be  comple-ted  by  the dissemination 
of  information  and  transfer  to  practical application.  Its  inclusion 
in  the  Comniunity' s  socio-economic  objec:tives  will  be  really 
efficient  only  if  the  innovation  can  be  pu~  into  application  under 
favourable  conditions  (for  example,  in  the  perspective of  solutions 
envisaged  in  the  Green  Paper  (1)  and  in  the  document  (2)  that 
followed  it  all  within  a  clear  and  fair  legal  and  regulatory 
framework  based  on  recognized  scientific  data  uniform  throughout 
Europe). 
This  is  the  purpose  of  the  Community's  biotechnology  activities  and 
their  effective  implementation  is  the  aim  of  the  concertation 
activity as  defined  by  the  Council  (decision of  12  March  1985,  O.J. 
No.1  83/1). 
(1)  COM(85)333  Perspectives  for  the  Common  Agricultural Policy 
(2)  COM(85)750  A  Future  for  Community  Agriculture 
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monitoring  and  strategic evaluation of developments  in biotechnology 
and  selective  dissemination  of  this  information  to  the  services 
concerned; 
support  or  .cooperation  available  to  those  responsible  for  policies 
implemented in  _.sectors  se.rved  by  biotechnology  or  sensitive  to  the 
spin-off from  biotechnology. 
An  initial review can already be made 
within  the  Commission,  dissemmination  of  information  and 
concertation  to  ensure  a  common  approach  in all  domaines  (R&D  and 
non  R&D)  touched  by  biotechnology; 
support· for  prqmotion  of  the  efficiency of  biotechnology  in  Europe 
in. the  service  of  socio-economic  objectives  through  a  range  of 
different  activities,  generally  carried  out.  in  the  context  of 
flexible  networks  (for  example,  organization  of  conferences  and  ad 
hoc  meetings  -with  all  those  concerned  research  scientists, 
manufacturers,  ·the  agricultural  world,  international  organizations 
such  as  the  OECD, .. WIPO,  EFB,  CEFIC,  GIFAP  and  COMASSO. 
:-.. 
·'· 
Those  responsible for  the·concertation activity have helped  to  organize 
large  international  conferences  such  as  that  held  by  CEPS  (Centre  for 
European  Policy  Studies),  Brussels,  on  "Industrial  biotechnology  in 
Europe  :  issues for p'ublic policy". 
A  conference  organized  by  BIQ-HELLAS  on  biotechnology  and  agriculture 
in  the  Mediterranean  basin  will  be  held  in  Athens  in  June  1986.  The 
following  year  a  seminar  will  be  organized  on  biotechnology  in  Europe· 
and  Latin  America  cooperation  .possibilities  (in  particular 
encouragement  of  dialogue  between  national  biotechnology  policy-makers 
and  contractors  to  promote  trade, investment,  joint  ventures  and  other 
channels  for  technology  transfer  and  cooperation  between  Europe  and 
Latin America). 
The  concertation  activity ·also  includes  the  promotion  and  exploration 
. of  new  activities,  the  strategic  aim  of  which  is  to  help  identify  new 
programmes  or  ventures  necessary  for  the  progress  of  European 
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objectives. 
The  discussion  paper  COM(86) 221,  "Biotechnology  in  the  Community 
Stimulating  Agro-Industrial  Development"  is  the  basis  for  a 
consultation  between  sciences,  agriculture  and  industry.  This  activity 
should  serve  to deepen understandiqg  on  the evolution of industrial use 
of  agricultural  products  on  the  one  hand,  and  on  the  contribution 
biotechnology  can  make  to  non~food  uses,  to  the  . production  of 
non-traditional  agricultural  products;  to  production  techniques,  to 
quality  diversificat.ion  and  to  environmental  protection. on  the  other. 
This  action  should  stimulate>  in  a  second  phase,  the  realisation  of· 
pilot projects. 
In  another  field  selected  because  ·of  its  importance  for  modern 
Biotechnology  the  exJ>loratory  venture  "BICEPS"  (Bio-Informatics 
Collaborative European Programmes  and  Strategy) .is designed  to evaluate 
trends  and  requirements,  and  possibly  planning  needs  in  the  field  of 
hie-informatics  (including medical  informatics). 
3.  NEED  TO  REVIEW  THE  BIOTECHNOLOGY  PROGRAMME 
3.1  Research activities 
It is essential  to  increase  the  volume  of  ongoing  activitfes under the 
BAP  in  order  to  enable  the  transnational  research  networks  that  have 
just  been  set  up  in  the  Community  to  attain  a  critical  scale  without 
diluting the  concentration of effort. 
Without  widening  the  research  spectrum,  it is necessary  to  increase  to 
25  - 30  the number  of  laboratories  involved  in each  of the sub-sections 
of  the  programme  which  are  regarded  as  particularly  important  for  the 
development  and  use  of  biotechnology  in  the  Community  (enzyme 
engineering,  applications  of  genetic  engineering  to  agriculture,  risk 
assessment,  contextual measures  to  improve  R&D  support facilities).  Now 
that  an  initial  network  of  good  university  laboratories  has  been  set 
up,  it is  necessary  to  involve  J<~uropean  industry  in  the  joint  effort 
and  to  step  up  Community  activities  for  the  disemination  and 
follow-through  of scientific results. 
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for  the  programme  show  that  this  increase  in  the  volume  of  activities 
is absolutely in line with the requirements of research scientists who, 
for  lack of  funds,  are  unable  to  carry  out  projects  that  could  make  a 
highly  significant contribution  to  the  development  of  biotechnology  in 
Europe.  Excellent  research  proposals  that  meet  the  criteria  of 
scientific  quality  and  transnational  involvement  and  are  also  _in  line 
with  the  specific  objectives  ·of  the  programme  have  been  entered  on 
reserve  lists  drawn  up  with  a  view  to  the  possible  revision  of  the 
Community  programme. 
As  in  the  case  of  research,.· it is  necessary  to  step  up  the  volume  of 
these  activities  which  provide  opportunities  for  young  scientists 
wishing to  specializ~e in one  of  the many  disciplines involved in modern 
biotechnology  to redeive  training  in the best  Community  centres. 
The  techniques  are  ~o  complex  and  knowledge  is  increasing so  fast  that 
only  if  a  great  ef~ort is  made  to  combine  training  capacities  in all 
the  Member  States <will  it be  possible  to  provide  industry  with  the 
research staff it nt!~eds  to  launch  or expand its R  &  D activities. 
With  existing  funds  it  is  possible  to  allocate  some  60  grants  or 
training  contracts  each  year  (on  average  five  per  Member  State).  This 
is certainly not  commensurate with Community  requirements. 
The  scheme-should  also give  some  Member  States less well  equipped  than 
others  in  the  way  of  research  laboratories  an  opportunity  to 
participate· fully  in  the- Community  programme  and  gradually  to:. acquire 
expertise of  a  high scientific level. 
3.3 Concertation activities 
The concertation activity covers  the  nine. tasks  defined  in  the Council. 
Decision  of  March  1985.  Briefly,  they  combine ·the  monitoring  of  new 
·developments  throughout  the world  with  the  provis.ion of  information  and 
assessments  to  the  Commission  and  the Member  States. These  tasks,  which 
provide  the  foundation  for  cooperation  and  .greater  coherence  .between 
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activities essential to  the development  of  European biotechnology,  call 
for  the  development  and  use  of  consultation  and  communications 
networks. 
Their  relevance  is  demonstrated  by  the  increase  in  the  number  of 
requests  received  by  those  managing  this  activity  as  a  result  of  the 
general expansion of  biotechnology and  the very great  interest  shown  by 
several  Community  bodies  (European  Parliament  •  hearings,  committee 
discussions,  parliamentary·questions;  various Commissions  departments  : 
problems  of  interaction  between  biotechnology  and  various  policy 
sectors  concerning  regulations,  social  impact,  etc.).  This  growing 
interest is also  found  outside the  Community  institutions  (for example, 
'the  meeting· in  December  1984  between  the  Corgmission  and  heads  of 
European  companies  gave  rise  to  the  European Biotechnology Coordination 
Group- EBCG.) . 
Activities  to  meet  ·these  demands  are  extremely  labour  intensive. 
Existing manpower  resources fall  so  short of  the requirements  resulting 
from  the  programme  that it is necessary  to  resort  to  expedienties  such 
as  the  taking  on of  temporary staff,  who  often  do  not  match  up  so  well 
to  the  requirements  for  correct  execution  of  the  tasks,  and 
subcontracting. 
4.  REVIEW  PROPOSALS 
The  aims  and  technical content of  this review are  as  follows 
Speeial  attention  should  be  given  i:o  the  three  areas  (bio-informatics, 
protein  design  and  plant· biochemistry)  whi.ch  suffer  most  severely  in 
the  Community  from  the  shortage  of  high-level .research  scientists.  The 
particularly acute  needs  of. :Some  l1ember  States  for  qualified staff  for 
various sectors of  the  programme ·should  be ·taken into account. 
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The  sectors of  the current  programme  which are of particular importance 
to  the  Community  and  for  the  development  of  its sectoral policies were 
identified  after  numerous  talks  with  experts  and  discussions  with 
national delegations  to the Biotechnology  CGC.  At  the  same  time  the  CGC 
chairman,  accompanied  by  ·Commission  representatives,  visited  the 
capitals of  the  Member  States.  During  these visits in-depth  talks with 
national  representatives  were  held;  the  advisability  of  revising  the 
programme  and  the  f'9rm  the  the  revision  should  take  were  examined  in 
detail.  This  high~~ighted  the  importance  of  expanding  Community  . ;;,\ 
fo;l:J;owing  areas  : 
·::~: 
meas·tl'res  (bioinformatics  .-...  :;r:.  Contextual  and  collections  of  biotic 
research in the 
.materials)  whe-rf§J[Community  support  must  lead  to  improved  faci:litiea · 
op_en  to· res·ea~;~}i~~~ientists· in. all Member  States. ·  · ·  ·  ...  >{~~-··  ·.·..  . 
.  . ~  ~---~~~  . · ... 
..,..  . B±oreac'tors' : ··tli·f's ·area,  es~·ential to  ~~he future  oL:bietechnolo_gy 
, <l  ;J,'':  ~~~::~~~  i!l~Jlii•:ait:::::n  m::::::::n~i~:::~··r··!:!:  .p;c:-~.:lLQJ!{>,.:,;,::::~/~ 
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products  avai'l!a:Q.~~  to  European  industry  • 
.  ~~, '."f~:{· 
Protein  engineet)  .. ng 
particularly  po<?.:rly 
This  very  promising  area  of  research  is 
financed  in  the  current  programme.  But  the 
United  States  and  Japan  support  major  efforts  in  this  area  the 
latter  country  having  adopted  an  ambitious  programme  in  1986.  A 
·concerted  effort~in Europe  should  open  up  new  methods  to  understand 
and  to  prepare ar-tificial proteins,  for  example  new  enzymes. 
Applications  of ;-genetic  engineering  it  was  undoubtedly  in  the 
applications  of ·genetic  engineering  to  the  dairy  industries  and  to 
·the  improvement  of  cultivated  species  that  the  Community  research 
set up  by  the  biomolecular engineering  programme  reached  the highest 
scientific  quali~y. 
The  European  laboratories  are  within  reach  of  various  spectacular 
*  achievements  in the  medium  term  for  the  dairy  industry  and  in  the 
longer  term  for  plant  improvement.  If  the  Community  is  to  keep  its 
lead,  which  is  due  in  part  to  cooperation  across  frontiers,  it  is 
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·· .. essential  to  step  up  the  current  effort  and  to  involve  European 
industry  right  now  in  the  research  being .done  under  the  existing 
programme. 
Assessment  of  risks  this  area,  which  is  of  great  importance  in 
view  of  the  extremely  rapid  pace  of  the  progress  made  by  man  in 
transforming,  taming  and  harnessing  the  properties  of  living matter 
on  a  large scale,  is confined  in  the  existing programme  to  contract 
research  by  five  laboratories.  This  embryonic  transnational research 
network,  which  for  the  moment  is  concentrating  mainly  on  the 
assessment  of  risks  ·that  may  be  associated  with  the  release  of 
modified  micro-organisms,  needs  to  be  greatly  reinforced  and  its 
objectives  diversified.  It  should  be  able  to  provide  scientific 
backing  for the various regulations needed  for  the harmonious 
development  of modern  biotechnology. 
In  each  of  these  areas  the  Commission  departments  plan  to  select  some  of 
the many  proposals  of  an  extremely high scientific level now  on  the reserve 
list and,  together with the project leaders  and manufacturers  interested in 
the  proposals,  to  lay  the  foundations  wherever  that  appears  desirable,  for 
contractual  agreements  making  Community  support  conditional  upon  the 
participation of  industry in  the  research work or its financing. 
The  planned  arrangements,  based  essentially  on  the  selection  of  proposals 
already  submitted  to  the  Commission,  should  allow  a  rapid start to  be  made 
on  new  contractual  activities  in  fields  regarded  as  essential  by  European 
industry. 
To  expand  the  scope  and  increase  the  efficiency  of  the  concertatiori 
activity  to  match  the realistic and  appropriate objectives of its brief 
as defined  in section 3.3,  an  increase  in staff will be  required. 
* Where  genetic engineering can  make  a  very significant contribution to 
improving  the quality and  yield  of fermentation process. 
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·'.  ··It.·. f:s' ·essential, ·to  :extend· ·the  ·programme ·and ,  .. :.j,;ts ;<revised  version. to '  , :  ·.  ··· 
·Spain.· an.d  .Portugal  and  -to··  ·include , these·  two  Membe.r  .States.  in . tl;le· 
research·,.  t-ra-ining  and  concertation networks  set ·up  ..  for the developmep..t 
· of. biotechnology in. ·the  Community  •.. · It 1s ·clear- from .numerous  tal-ks .with 
national officials· and· :the .,scientific  community  in those :two -countries 
· . "··that  Spain  and  Portugal  can  .make  a  .very  useful:.·:.cont.ribution . to  ..  the. 
Community activities in progress "and, .like ·.the. other Member  States,  can 
benefit  from  the  transnational  dimension  of  the  programme  and  its 
concentration  on·  finding  long-term  solutions  to  major  ..  Community 
problems. 
5.  COMPATIBILITY  WITH  THE  FRAMEWORK  PROGRAMME 
In  its  resolution  of  25  July  1983  on  a. first  framework  programme 
. (1984-1987)  for  .Community ..  ,research,~· , development  · and  .demonstrat-ion 
·-- ....  ·activities,  .. the· Counci·l  approved the  ,,development . of .biotechnology ,unde.r  t.he. 
goal o.f :promoting ind.ustrial·· competitiveness. 
The· .draft  framework~programme.~for 1987-1·991 .. is ·now  being -prepared;  it plans 
to  increase  .the  research,·  training·· ·and  concertation  activities  ·in 
biotechnology. 
6.  CONSULTATION  OF  THE  .BIOTECHNOLOGY  CGC 
The  results obtained under  the biomolecular engineering  programme  have  been 
evaluated by  the  Biotechnology.CGC,  which .recognized  the scientific quality 
of the  programme. 
It  considers  that  "its most  convincing· result  is  undoubtedly  the  creation 
of  a·climate  favourable  to  transnational cooperation,  the effects of which 
go  well beyond  the hopes  expressed when  the  programme  was  launched'\. 
All  the delegations  to  the  CGC  recognize  that  the principle of revising  the 
biotechnology programme  is both justified and  useful.  A very large majority 
would  like to  see  a  substantial.increase in its funding. 
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Several  delegations  regard  the  revision as  a  transitional phase  leading  to 
a  better  understanding  of  the  requirements  for  the  transfer  of  technology 
and  follow-through  of  results,  which  could  be  taken  into account in 1989  by 
the  second-generation programme  (BAP  II). 
BRl/06  - 15  -7.  CONCLUSION 
In  the  light of  the  Council's  and  the  European  Parliament's discussions  on 
the  general  orientations  for  the  Framework  Programme  for  Community  RD&T 
activities  1987-1991,  and  the  terms  of  the  formal  Framework  Programme 
proposal  which  it adopts,  the  Commission  will  prepare  and  submit  a  draft 
Council  decision  for  the  revision  of  the  Research  Action  Programme 
"Biotechnology"  1985-1989. 
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